Pagaya Technologies: Sustained Growth and Operational Efficiency Bolster Strong Buy Rating
Finance

Pagaya Technologies: Sustained Growth and Operational Efficiency Bolster Strong Buy Rating

authorBy Strive Masiyiwa
DateAug 18, 2026
Read time2 min
This document presents an in-depth review of Pagaya Technologies, reinforcing its investment appeal and adjusting its financial outlook based on recent performance. The analysis highlights the company's robust operational achievements and strategic positioning in the AI-driven lending sector.

Unlocking Value: Pagaya's Path to Enhanced Profitability

Reaffirming Confidence in Pagaya Technologies

I am once again endorsing Pagaya Technologies, maintaining a "Strong Buy" recommendation. However, a revision to the price target has been made, moving from $74 to $67 per share, reflecting adjustments for a higher share count and increased net debt. This reiteration follows a thorough evaluation of the company's impressive Q2 2026 earnings performance.

Q2 2026 Performance Highlights: A Testament to AI Innovation

Pagaya's Q2 2026 financial outcomes provide compelling evidence of the efficacy and scalability of its AI-powered lending platform. The company reported a significant 33% surge in network volume, alongside a 43% increase in adjusted EBITDA. These figures are indicative of Pagaya's growing operational leverage and its capacity to achieve profitable expansion in the competitive financial technology landscape.

Operational Efficiency Driving Margin Expansion

A notable achievement in the recent quarter was the 6% reduction in core operating expenses, occurring concurrently with the substantial growth in network volume. This strategic cost management contributed to an adjusted EBITDA margin of 32%, underscoring the company's commitment to and success in fostering scalable profitability. Such efficiency gains are pivotal in reinforcing investor confidence in Pagaya's long-term financial health.

Navigating Risks with Robust Performance

While Pagaya's operational strengths are clear, potential risks such as retained credit exposure and possible compression in FRLPC margins have been acknowledged. Despite these considerations, the company's resilient operating performance justifies its current valuation at 15 times forward EV/EBITDA. The market is seen to be appropriately valuing Pagaya's innovative approach and its demonstrated ability to generate strong financial results.

More Articles
Finance
U.S. Equity Market Dynamics and Factor Investing in 2026
The initial seven months of 2026 saw strong U.S. equity performance, despite underlying economic uncertainties. The S&P 500 Momentum Index significantly outperformed, reflecting a high-dispersion market. A negative correlation between the S&P 500 Low Volatility and Momentum Indices suggests diversification benefits, with a 50/50 blend showing superior returns and lower volatility over 30 years.
By Morgan HouselAug 18, 2026
Finance
Artiva Biotherapeutics: Pioneering NK Cell Therapy for Autoimmune Diseases
Artiva Biotherapeutics is making significant strides with its off-the-shelf natural killer (NK) cell therapy, AlloNK, targeting refractory rheumatoid arthritis (RA) and other B-cell autoimmune diseases. Early basket studies have shown promising efficacy and a favorable safety profile, with a 71% ACR50 response in RA patients and no serious adverse events linked to the therapy. The company plans to initiate a Phase 3 RA trial in the second half of 2026, with pivotal data anticipated by the second half of 2028, aiming to capture a substantial domestic market opportunity in fourth-line RA.
By David RubensteinAug 18, 2026
Finance
UK Job Market Weakness Persists Despite Economic Growth, Bank of England Rate Cuts Expected in 2027
Despite recent indications of economic recovery in the UK, the labor market continues to show significant weakness, particularly in private sector hiring and wage growth. This persistent softness in employment metrics suggests a high bar for any interest rate hikes by the Bank of England in the near future, unless a severe and prolonged surge in energy prices occurs. Analysts anticipate the Bank of England will maintain current interest rates throughout the remainder of this year, with a projected resumption of rate cuts commencing in the spring of 2027. Consumer-facing industries, such as hospitality and retail, are notably shedding jobs at an accelerating pace.
By David RubensteinAug 18, 2026
Finance
StoneCo's Q2 Performance and Future Outlook: A Skeptical View
StoneCo's Q2 results show weak revenue growth and missed EPS expectations. The company's pivot towards credit to drive growth is concerning due to rising delinquencies. High interest rates and a challenging macroeconomic environment in Brazil further pressure profitability. Despite a seemingly low P/E, the valuation reflects inherent risks, leading to a 'Hold' rating.
By Robert KiyosakiAug 18, 2026
Finance
New Mountain Finance: Navigating Dividend Adjustments and Portfolio Shifts
New Mountain Finance (NMFC) recently revised its dividend down by 22% to $0.25 per share. This adjustment was a response to a considerable reduction in its portfolio size and a corresponding decrease in net investment income. Despite these changes, the firm maintains a 'Buy' rating. The dividend reset has bolstered coverage to 104% in Q2, addressing immediate concerns about payment sustainability. The market appears to have already factored in the dividend cut, as the stock's discount to Net Asset Value (NAV) has not widened. Management is actively utilizing this persistent NAV discount for strategic capital allocation, including aggressive stock buybacks.
By Nouriel RoubiniAug 18, 2026